[Myoclonic epilepsy of Lafora: a case report]
- PMID: 20873469
[Myoclonic epilepsy of Lafora: a case report]
Abstract
Myoclonic epilepsy of Lafora (EPM2) is a severe autosomal recessive disorder. The onset in adolescence, generalized seizures, severe myoclonus, dementia and a rapid malignant course with death in 4-8 years after the onset are characteristic features of EPM2. The disease has a specific pathological feature, intracellular polyglucosan inclusions (Lafora bodies) in the brain, liver, skin and muscles. Two genetic forms are known, one of which (EPM2A) is caused by mutations in the laforin gene and another (EPM2B)--by mutations in the malin gene. We report a case of EPM2A in a 17-year-old girl of mixed Russian-Ukrainian ethnicity. The disease lasted for almost four years by the time of the examination but the girl still had no dementia. A previously described laforin mutation Tyr86Stop in the homozygous state was detected and Lafora bodies were found in the skin and muscles. Various anticonvulsants produced no effect or a slight and unstable effect. In the following several months, the disease progressed quickly, the girl became severely disabled and demented and died in 19 years old, 5.5 years after the disease onset. This is a first Russian case confirmed by DNA testing.
Similar articles
-
[Lafora's disease presenting with progressive myoclonus epilepsy].Rev Neurol (Paris). 2007 Oct;163(10):975-8. doi: 10.1016/s0035-3787(07)92642-9. Rev Neurol (Paris). 2007. PMID: 18033035 French.
-
Advances in lafora progressive myoclonus epilepsy.Curr Neurol Neurosci Rep. 2007 Sep;7(5):428-33. doi: 10.1007/s11910-007-0066-7. Curr Neurol Neurosci Rep. 2007. PMID: 17764634 Review.
-
[Lafora disease. A new case of confirmation of diagnosis on molecular genetic studies].Rev Neurol. 2002 Jan 16-31;34(2):117-20. Rev Neurol. 2002. PMID: 11988905 Spanish.
-
Three patients with lafora disease: different clinical presentations and a novel mutation.J Child Neurol. 2015 May;30(6):777-81. doi: 10.1177/0883073814535489. Epub 2014 Jul 10. J Child Neurol. 2015. PMID: 25015673
-
Lafora disease: epidemiology, pathophysiology and management.CNS Drugs. 2010 Jul;24(7):549-61. doi: 10.2165/11319250-000000000-00000. CNS Drugs. 2010. PMID: 20527995 Review.
Cited by
-
Neuromuscular junction dysfunction in Lafora disease.Dis Model Mech. 2024 Oct 1;17(10):dmm050905. doi: 10.1242/dmm.050905. Epub 2024 Oct 14. Dis Model Mech. 2024. PMID: 39301689 Free PMC article.
-
Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis.Orphanet J Rare Dis. 2021 Aug 16;16(1):362. doi: 10.1186/s13023-021-01989-w. Orphanet J Rare Dis. 2021. PMID: 34399803 Free PMC article.